An exploratory double-blind, single-dose, 2-treatment, 2-period, randomized, crossover phase I study of KP511 in healthy volunteers

Trial Profile

An exploratory double-blind, single-dose, 2-treatment, 2-period, randomized, crossover phase I study of KP511 in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Jan 2017

At a glance

  • Drugs KP 511 (Primary) ; Hydromorphone
  • Indications Acute pain
  • Focus Pharmacokinetics; Proof of concept
  • Most Recent Events

    • 09 Jan 2017 Results published in a KemPharm media release.
    • 30 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top